All
Measuring the Economic Burden for Patients With Vitiligo
People with vitiligo in the US face burdensome health care expenses, including expenses seemingly unrelated to the condition, according to 1 study.
Topical Treatments, Minoxidil Solutions Found Most Effective in Wide Review of Pediatric Alopecia Therapies
Researchers in China reviewed topical modalities, minoxidil solutions, tofacitinib, and microneedling for pediatric AA.
Line-Field Confocal Optical Coherence Tomography Exhibits Highest Sensitivity and Negative Predictive Value in Onychomycosis
LC-OCT demonstrated higher sensitivity and negative predictive value compared to other methods of diagnosis and detection.
Dermatology Conferences and Meetings Calendar 2024: February
Dermatology Times asked our readers to share what conferences they are looking forward to in the first quarter of 2024.
An OTC Moisturizer’s Effects on Skin Ceramide Levels
An OTC moisturizer was found to improve skin ceramide levels in patients with eczema-prone skin.
Clinical Characteristics of Melanoma in Black Patients Identified
A new report looking at melanoma in Black patients adds much-needed clinical insights.
Glynis Ablon, MD, Previews IMCAS World Congress 2024
Ablon’s session highlights include best practices for hair restoration.
Interview Intersection: Expert Interviews From January 2024
Dermatology Times is recapping our top expert interviews from the month of January.
Almirall Announces Partnership With Microsoft for Digital Transformation, Development of Skin Disease Treatments
The 3-year partnership and collaboration will employ the use of generative artificial intelligence and analytics technologies.
Dermatology Times January 2024 Recap
Dermatology Times is looking back on the top stories in dermatology from the month of January.
Discovering Dermatology Times: January 2024
Learn more about the in-depth topics covered in the January 2024 print issue of Dermatology Times.
New Molecule Shows Promise in Treating Atopic Dermatitis and Inflammatory Bowel Disease
Positive results in preclinical animal trials of DPT0218 may lead to advances in clinical treatment of autoimmune diseases.
Vitiligo and Retinal Detachment: Is There a Connection?
People with vitiligo face a higher risk of retinal detachment, according to a study in Taiwan.
Psychological Stress Exacerbates Brain Activities in Female Patients With Atopic Dermatitis
Functional magnetic resonance imaging response was utilized to test motor, somatosensory association cortex, perception, and sensory integration processing in a recent study.
Previewing Editorial Advisory Board Member Sessions at IMCAS World Congress 2024
Among the many sessions to be held at the IMCAS World Congress 2024 in Paris, France, several Dermatology Times Editorial Advisory Board members are preparing to share their knowledge and insights.
Discovering Dermatology Times: January 2024 Topical Treatments for Vitiligo Supplement
Learn more about the in-depth topics covered in the January 2024 topical treatments for vitiligo supplement of Dermatology Times.
Dupilumab Plus Antihistamines Beats Antihistamines Alone in Treating CSU
Patients with chronic spontaneous urticaria saw improvement in itch and hive severity when dupilumab was added to their antihistamines in a 24-week study.
Is CPS the Solution for Refractory Plantar Warts?
An immunosuppressed patient with refractory plantar warts showed improvement following cantharidinpodophyllotoxin-salicylic acid (CPS) monotherapy.
Verrica Receives Permanent J-Code for Ycanth for Molluscum Contagiosum
The Centers for Medicare & Medicaid Services has issued a permanent J-code for the first and only FDA-approved treatment for molluscum contagiosum.
Marcelo Bigal, MD, PhD: VENT-03's Modality Offers Hope for Targeted Therapy in Skin Disorders
Marcelo Bigal, MD, PhD, discusses VENT-03's potential as a small molecule therapeutic in dermatology, among other fields.
Efinaconazole Demonstrates Superior Transungual Penetration Compared to Other Antifungal Treatments
Topical antifungals, whether FDA-approved or available over-the-counter, exhibited more effective penetration through cellulose disks than cadaver nails.
POLL: Are You Attending IMCAS World Congress 2024?
Let us know if you plan to attend IMCAS World Congress 2024.
The Weekly Roundup: January 22-26
ICYMI, this week we had news about the completion of LEO Pharma's acquisition of Timber Pharmaceuticals, research pointing to melanoma overdiagnosis in White patients, artificial intelligence in skin cancer detection, and more.
Light-Responsive Drug Delivery System for Skin Cancer Holds Promise
The novel nanofiber-based system holds promise for future nanotech applications in health care, researchers claim.
'Considerable Number’ of Pregnancies Reported Among Women and Girls Using Isotretinoin in Germany
A population-based study found a 63% increase in isotretinoin use in the years 2004 to 2019, and an increase in isotretinoin-exposed pregnancies as well.
The Year Ahead in Dermatology
So far, 2024 is shaping up to be just as busy as 2023 with new dermatology innovations, approvals, and data. Review what's still to come in 2024.
Higher Scalp Hair Loss Linked to Noticeable Gaps or Absence in Eyebrow and Eyelash Hair in Patient Study
A poster analyzing the BRAVE-AA study population was presented at Maui Derm Hawaii 2024.
How to Handle Social Media Retaliation
A patient's social media post has gone viral and has been seen by thousands. Dr Derm is concerned this malicious act may ruin his career. What can he do?
Study Points Toward Stark Disparity of Academic Papers Referencing Sunscreen in Patients With Skin of Color
A poster from Maui Derm Hawaii revealed an even more significant disparity than researchers anticipated.
Patient Preferences in Atopic Dermatitis Treatment
Patients with moderate to severe AD gave their opinions in a survey on treatment options and their tradeoffs. Itch control topped the list of patient concerns.